| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A compass for navigating the perils of hypertriglyceridaemia
|
Watts, Gerald F
|
|
|
|
5 |
p. 248-249
|
artikel
|
| 2 |
Active commuting and obesity in mid-life: cross-sectional, observational evidence from UK Biobank
|
Flint, Ellen
|
|
2016
|
|
5 |
p. 420-435
16 p.
|
artikel
|
| 3 |
Active commuting: an easy and effective way to improve health
|
Andersen, Lars Bo
|
|
2016
|
|
5 |
p. 381-382
2 p.
|
artikel
|
| 4 |
Addressing health disparities: no time like the present
|
The Lancet Diabetes & Endocrinology,
|
|
|
|
5 |
p. 247
|
artikel
|
| 5 |
Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies
|
Auernhammer, Christoph J
|
|
2018
|
|
5 |
p. 404-415
|
artikel
|
| 6 |
Analogue insulin as an essential medicine: the need for more evidence and lower prices
|
Beran, David
|
|
2019
|
|
5 |
p. 338
|
artikel
|
| 7 |
Analysis of the MAVIDOS trial
|
Kovacs, Christopher S
|
|
2017
|
|
5 |
p. 328-
1 p.
|
artikel
|
| 8 |
Analysis of the MAVIDOS trial – Author's reply
|
Harvey, Nicholas C
|
|
2017
|
|
5 |
p. 328-329
2 p.
|
artikel
|
| 9 |
Anand Hardikar: a scientific nomad searching for the truth
|
Rahimi, Susan
|
|
|
|
5 |
p. 304
|
artikel
|
| 10 |
A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys
|
Hajifathalian, Kaveh
|
|
2015
|
|
5 |
p. 339-355
17 p.
|
artikel
|
| 11 |
Answering clinically pertinent questions with real-world data from paediatric type 1 diabetes registries
|
Galderisi, Alfonso
|
|
|
|
5 |
p. 300-301
|
artikel
|
| 12 |
Are light masks useful for early diabetic macular oedema?
|
Wong, Tien Yin
|
|
2018
|
|
5 |
p. 352-354
|
artikel
|
| 13 |
Associations of the glycaemic index and the glycaemic load with risk of type 2 diabetes in 127 594 people from 20 countries (PURE): a prospective cohort study
|
Miller, Victoria
|
|
|
|
5 |
p. 330-338
|
artikel
|
| 14 |
Bariatric surgery in adolescents
|
Zhang, Yu
|
|
2017
|
|
5 |
p. 326-
1 p.
|
artikel
|
| 15 |
Bariatric surgery in adolescents – Author's reply
|
Olbers, Torsten
|
|
2017
|
|
5 |
p. 326-327
2 p.
|
artikel
|
| 16 |
Blood pressure goals in type 2 diabetes—assessing the evidence
|
Nilsson, Peter M
|
|
2017
|
|
5 |
p. 319-321
3 p.
|
artikel
|
| 17 |
Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders
|
Vervloet, Marc G
|
|
2014
|
|
5 |
p. 427-436
10 p.
|
artikel
|
| 18 |
Breakthrough technology for in-hospital glucose monitoring
|
Kerr, David
|
|
|
|
5 |
p. 304-306
|
artikel
|
| 19 |
Calcified nodules on fingers in primary hyperoxaluria type 2
|
Yamanouchi, Masayuki
|
|
2016
|
|
5 |
p. 468-
1 p.
|
artikel
|
| 20 |
Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes?
|
Schernthaner, Guntram
|
|
|
|
5 |
p. 251-252
|
artikel
|
| 21 |
Cardiorenal risk reduction guidance in diabetes: can we reach consensus?
|
Sattar, Naveed
|
|
|
|
5 |
p. 357-360
|
artikel
|
| 22 |
Cardiovascular and heart failure outcomes with type 2 diabetes therapies: how important is weight loss?
|
Avogaro, Angelo
|
|
|
|
5 |
p. 353-355
|
artikel
|
| 23 |
Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988–2014
|
Ali, Mohammed K
|
|
2018
|
|
5 |
p. 392-403
|
artikel
|
| 24 |
Cardiovascular disease risk in type 1 diabetes
|
Anagnostis, Panagiotis
|
|
2015
|
|
5 |
p. 316-317
2 p.
|
artikel
|
| 25 |
Cardiovascular disease risk in type 1 diabetes – Authors' reply
|
Huxley, Rachel R
|
|
2015
|
|
5 |
p. 317-
1 p.
|
artikel
|
| 26 |
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study
|
Di Dalmazi, Guido
|
|
2014
|
|
5 |
p. 396-405
10 p.
|
artikel
|
| 27 |
Caring for people with diabetes and non-communicable diseases in Ukraine: a humanitarian emergency
|
Maystruk, Galyna
|
|
|
|
5 |
p. 308
|
artikel
|
| 28 |
β-cell secretory dysfunction: a key cause of type 2 diabetes
|
Holman, Rury R
|
|
|
|
5 |
p. 370
|
artikel
|
| 29 |
β-cell secretory dysfunction: a key cause of type 2 diabetes – Authors' reply
|
Weir, Gordon C
|
|
|
|
5 |
p. 370-371
|
artikel
|
| 30 |
Change in albuminuria as a surrogate endpoint in chronic kidney disease
|
Zhao, Hai-Lu
|
|
2019
|
|
5 |
p. 335-336
|
artikel
|
| 31 |
Change in albuminuria as a surrogate endpoint in chronic kidney disease
|
Pyne, Lonnie
|
|
2019
|
|
5 |
p. 335
|
artikel
|
| 32 |
Change in albuminuria as a surrogate endpoint in chronic kidney disease – Authors' reply
|
Heerspink, Hiddo J L
|
|
2019
|
|
5 |
p. 336-337
|
artikel
|
| 33 |
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants
|
Taïeb, David
|
|
|
|
5 |
p. 345-361
|
artikel
|
| 34 |
Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial
|
Sivaprasad, Sobha
|
|
2018
|
|
5 |
p. 382-391
|
artikel
|
| 35 |
Colliding epidemics requires collaborating programmes
|
Lönnroth, Knut
|
|
2015
|
|
5 |
p. 306-307
2 p.
|
artikel
|
| 36 |
Continuous glucose monitoring versus blood glucose monitoring for risk of severe hypoglycaemia and diabetic ketoacidosis in children, adolescents, and young adults with type 1 diabetes: a population-based study
|
Karges, Beate
|
|
|
|
5 |
p. 314-323
|
artikel
|
| 37 |
Correction for Lancet Diabetes Endocrinol 2014; published online April 8
|
|
|
2014
|
|
5 |
p. e12-
1 p.
|
artikel
|
| 38 |
Correction for Lancet Diabetes Endocrinol 2014; published online March 25
|
|
|
2014
|
|
5 |
p. e12-
1 p.
|
artikel
|
| 39 |
Corrections needed to 2016 ESC guideline and AHA scientific statement on heart failure
|
Rydén, Lars
|
|
2017
|
|
5 |
p. 325-326
2 p.
|
artikel
|
| 40 |
Correction to Lancet Diabetes Endocrinol 2017: 5: 125–33
|
|
|
2017
|
|
5 |
p. e3-
1 p.
|
artikel
|
| 41 |
Correction to Lancet Diabetes Endocrinol 2017; 5: 240–41
|
|
|
2017
|
|
5 |
p. e3-
1 p.
|
artikel
|
| 42 |
Correction to Lancet Diabetes Endocrinol 2017: 5: 174–83
|
|
|
2017
|
|
5 |
p. e3-
1 p.
|
artikel
|
| 43 |
Correction to Lancet Diabetes Endocrinol 2017; 5: 877–86
|
|
|
2019
|
|
5 |
p. e5
|
artikel
|
| 44 |
Correction to Lancet Diabetes Endocrinol 2019; 7:288–99
|
|
|
2019
|
|
5 |
p. e5
|
artikel
|
| 45 |
Correction to Lancet Diabetes Endocrinol 2016; 4: 633–35
|
|
|
2019
|
|
5 |
p. e5
|
artikel
|
| 46 |
Correction to Lancet Diabetes Endocrinol 2023; 11: 86–95
|
|
|
|
|
5 |
p. e7
|
artikel
|
| 47 |
Correction to Lancet Diabetes Endocrinol 2018; published online Dec 19. https://doi.org/10.1016/S2213-8587(18)30263-8
|
|
|
2019
|
|
5 |
p. e5
|
artikel
|
| 48 |
Correction to Lancet Diabetes Endocrinol 2017; published online Jan 23. http://dx.doi.org/10.1016/S2213-8587(17)30014-1
|
|
|
2017
|
|
5 |
p. e3-
1 p.
|
artikel
|
| 49 |
Correction to Lancet Diabetes Endocrinol 2017; published online Jan 25. http://dx.doi.org/10.1016/S2213-8587(17)30033-5
|
|
|
2017
|
|
5 |
p. e3-
1 p.
|
artikel
|
| 50 |
Correction to Lancet Diabetes Endocrinol 2019; published online March 1. DOI:10.1016/ S2213-8587(19)30066-X
|
|
|
2019
|
|
5 |
p. e5
|
artikel
|
| 51 |
Correction to Lancet Diabetes Endocrinol 2016; published online March 1. http://dx.doi.org/10.1016/S2213-8587(16)00079-6
|
|
|
2016
|
|
5 |
p. e5-
1 p.
|
artikel
|
| 52 |
Correction to Lancet Diabetes Endocrinol 2015; published online Nov 2. http://dx.doi.org/10.1016/S2213-8587(15)00372-1
|
|
|
2016
|
|
5 |
p. e5-
1 p.
|
artikel
|
| 53 |
Country in Focus: diabetes prevalence on the rise in Turkey
|
Burki, Talha
|
|
2016
|
|
5 |
p. 391-392
2 p.
|
artikel
|
| 54 |
Country in Focus: health disparities in Indigenous Canadians
|
Pirisi, Angela
|
|
2015
|
|
5 |
p. 319-
1 p.
|
artikel
|
| 55 |
Dapagliflozin in young people with type 2 diabetes
|
Tommerdahl, Kalie L
|
|
|
|
5 |
p. 303-304
|
artikel
|
| 56 |
Defining autoimmunity: an epistemological history
|
Linklater, Sarah
|
|
2015
|
|
5 |
p. 321-
1 p.
|
artikel
|
| 57 |
Defining gestational diabetes: not just about cutoffs
|
Simmons, David
|
|
|
|
5 |
p. 303-304
|
artikel
|
| 58 |
Definition and management of radioactive iodine-refractory differentiated thyroid cancer
|
Schlumberger, Martin
|
|
2014
|
|
5 |
p. 356-358
3 p.
|
artikel
|
| 59 |
Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Leere, Julius Simoni
|
|
|
|
5 |
p. 407-417
|
artikel
|
| 60 |
Diabetes behind bars: challenging inadequate care in prisons
|
The Lancet Diabetes & Endocrinology,
|
|
2018
|
|
5 |
p. 347
|
artikel
|
| 61 |
Diabetes in Pakistan: addressing the crisis
|
Bhutta, Zulfiqar A
|
|
|
|
5 |
p. 309-310
|
artikel
|
| 62 |
Diabetes in Scotland: a rising tide
|
Colhoun, Helen M
|
|
|
|
5 |
p. 375-376
|
artikel
|
| 63 |
Diagnosis of diabetes type in children and young people: challenges and recommendations
|
Amed, Shazhan
|
|
2016
|
|
5 |
p. 385-386
2 p.
|
artikel
|
| 64 |
Direct-to-consumer services: improving access to care for people with diabetes and obesity
|
Burki, Talha
|
|
|
|
5 |
p. 305
|
artikel
|
| 65 |
Disparities in fragility fracture and osteoporosis care in Africa
|
Ward, Kate A
|
|
|
|
5 |
p. 294-296
|
artikel
|
| 66 |
Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications
|
Stefan, Norbert
|
|
2016
|
|
5 |
p. 457-467
11 p.
|
artikel
|
| 67 |
Does addressing prediabetes help to improve population health?
|
Kivimäki, Mika
|
|
2018
|
|
5 |
p. 354-356
|
artikel
|
| 68 |
Does fetal exposure to vitamin D programme childhood bone mass?
|
Kovacs, Christopher S
|
|
2017
|
|
5 |
p. 317-319
3 p.
|
artikel
|
| 69 |
Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial
|
Yamada, Yuichiro
|
|
|
|
5 |
p. 377-391
|
artikel
|
| 70 |
DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting database
|
Gouverneur, Amandine
|
|
|
|
5 |
p. 365-367
|
artikel
|
| 71 |
Dreaming of normoglycaemia with fewer diet restrictions
|
Ruggenenti, Piero
|
|
2014
|
|
5 |
p. 350-351
2 p.
|
artikel
|
| 72 |
Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial
|
Ludvik, Bernhard
|
|
2018
|
|
5 |
p. 370-381
|
artikel
|
| 73 |
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial
|
Lean, Michael E J
|
|
2019
|
|
5 |
p. 344-355
|
artikel
|
| 74 |
Earth Day: time for transformational change
|
The Lancet Diabetes & Endocrinology,
|
|
|
|
5 |
p. 285
|
artikel
|
| 75 |
EDCs: regulation still lagging behind evidence
|
The Lancet Diabetes & Endocrinology,
|
|
2019
|
|
5 |
p. 325
|
artikel
|
| 76 |
Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial
|
Estruch, Ramon
|
|
2019
|
|
5 |
p. e6-e17
|
artikel
|
| 77 |
Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study
|
Pan, Sung-Ching
|
|
2015
|
|
5 |
p. 323-330
8 p.
|
artikel
|
| 78 |
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial
|
Seferovic, Jelena P
|
|
2017
|
|
5 |
p. 333-340
8 p.
|
artikel
|
| 79 |
Effects of RAS inhibitors on diabetic retinopathy
|
Parving, Hans-Henrik
|
|
2015
|
|
5 |
p. 315-316
2 p.
|
artikel
|
| 80 |
Effects of RAS inhibitors on diabetic retinopathy – Authors' reply
|
van Sloten, Thomas T
|
|
2015
|
|
5 |
p. 316-
1 p.
|
artikel
|
| 81 |
Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis
|
Wu, Jason H Y
|
|
2016
|
|
5 |
p. 411-419
9 p.
|
artikel
|
| 82 |
Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial
|
Kwakernaak, Arjan J
|
|
2014
|
|
5 |
p. 385-395
11 p.
|
artikel
|
| 83 |
Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis
|
|
|
|
|
5 |
p. 306-319
|
artikel
|
| 84 |
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study
|
Tamborlane, William V
|
|
|
|
5 |
p. 341-350
|
artikel
|
| 85 |
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
|
Barnett, Anthony H
|
|
2014
|
|
5 |
p. 369-384
16 p.
|
artikel
|
| 86 |
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial
|
Aroda, Vanita R
|
|
2017
|
|
5 |
p. 355-366
12 p.
|
artikel
|
| 87 |
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
|
Ahrén, Bo
|
|
2017
|
|
5 |
p. 341-354
14 p.
|
artikel
|
| 88 |
Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
|
Gouni-Berthold, Ioanna
|
|
|
|
5 |
p. 264-275
|
artikel
|
| 89 |
Elaine Rush: champion of physical activity and nutrition
|
Kirby, Tony
|
|
2015
|
|
5 |
p. 320-
1 p.
|
artikel
|
| 90 |
Endocrine health in survivors of adult-onset cancer
|
Link-Rachner, Cornelia S
|
|
|
|
5 |
p. 350-364
|
artikel
|
| 91 |
Endpoints for clinical trials in type 1 diabetes drug development
|
Galderisi, Alfonso
|
|
|
|
5 |
p. 297-299
|
artikel
|
| 92 |
Environmental chemical obesogens, what can we do?
|
Lobstein, Tim
|
|
|
|
5 |
p. 302-303
|
artikel
|
| 93 |
Essential medicines and access to insulin
|
Gill, Geoff
|
|
2017
|
|
5 |
p. 324-325
2 p.
|
artikel
|
| 94 |
Exercise management in type 1 diabetes: a consensus statement
|
Riddell, Michael C
|
|
2017
|
|
5 |
p. 377-390
14 p.
|
artikel
|
| 95 |
Exposure to endocrine-disrupting chemicals in utero and thyroid cancer risk in offspring
|
Das, Ankan Mukherjee
|
|
|
|
5 |
p. 255
|
artikel
|
| 96 |
Exposure to endocrine-disrupting chemicals in utero and thyroid cancer risk in offspring – Authors' reply
|
Kitahara, Cari M
|
|
|
|
5 |
p. 255-256
|
artikel
|
| 97 |
Familial aggregation and heritability of childhood-onset and adult-onset type 1 diabetes: a Swedish register-based cohort study
|
Wei, Yuxia
|
|
|
|
5 |
p. 320-329
|
artikel
|
| 98 |
Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease
|
de Vries, Aiko P J
|
|
2014
|
|
5 |
p. 417-426
10 p.
|
artikel
|
| 99 |
Fluid volume regulation in patients with heart failure
|
Anyfanti, Panagiota
|
|
|
|
5 |
p. 257-258
|
artikel
|
| 100 |
Fluid volume regulation in patients with heart failure
|
Tanaka, Atsushi
|
|
|
|
5 |
p. 256-257
|
artikel
|
| 101 |
Fluid volume regulation in patients with heart failure – Authors' reply
|
Jensen, Jesper
|
|
|
|
5 |
p. 258
|
artikel
|
| 102 |
Food additive emulsifiers and the risk of type 2 diabetes: analysis of data from the NutriNet-Santé prospective cohort study
|
Salame, Clara
|
|
|
|
5 |
p. 339-349
|
artikel
|
| 103 |
Food additive emulsifiers: a new risk factor for type 2 diabetes?
|
Du, Mengxi
|
|
|
|
5 |
p. 291-292
|
artikel
|
| 104 |
Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study
|
Mo, Daojun
|
|
2015
|
|
5 |
p. 331-338
8 p.
|
artikel
|
| 105 |
Francesco Rubino: formerly reluctant bariatric surgeon
|
Mitchell, Fiona
|
|
|
|
5 |
p. 372
|
artikel
|
| 106 |
Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial
|
Boughton, Charlotte K
|
|
2019
|
|
5 |
p. 368-377
|
artikel
|
| 107 |
Giovanni Strippoli: finding the pleasures in nephrology
|
Burki, Talha Khan
|
|
2014
|
|
5 |
p. 367-
1 p.
|
artikel
|
| 108 |
Giving NCDs the attention they deserve
|
Morgan, Jules
|
|
|
|
5 |
p. 373
|
artikel
|
| 109 |
GLP-1 and the renin–angiotensin–aldosterone system
|
Jiménez, David León
|
|
2019
|
|
5 |
p. 337
|
artikel
|
| 110 |
Glucose intolerance in pregnancy and risk of early-onset type 2 diabetes: a population-based cohort study
|
Bardugo, Aya
|
|
|
|
5 |
p. 333-344
|
artikel
|
| 111 |
Glucose-lowering and heart failure: risks of errors
|
van der Horst, Iwan C C
|
|
2015
|
|
5 |
p. 310-312
3 p.
|
artikel
|
| 112 |
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
|
Udell, Jacob A
|
|
2015
|
|
5 |
p. 356-366
11 p.
|
artikel
|
| 113 |
Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials
|
Ghosh-Swaby, Olivia R
|
|
|
|
5 |
p. 418-435
|
artikel
|
| 114 |
Glucose screening in pregnancy and future risk of cardiovascular disease in women: a retrospective, population-based cohort study
|
Retnakaran, Ravi
|
|
2019
|
|
5 |
p. 378-384
|
artikel
|
| 115 |
Glycaemic control and weight loss with semaglutide in type 2 diabetes
|
Madsbad, Sten
|
|
2017
|
|
5 |
p. 315-317
3 p.
|
artikel
|
| 116 |
Glycaemic control in heart failure: a PARADIGM shift for patients with concomitant diabetes?
|
Giamouzis, Gregory
|
|
2017
|
|
5 |
p. 314-315
2 p.
|
artikel
|
| 117 |
Glycaemic control on nutritional support: finding stability in unstable times
|
Gillard, Pieter
|
|
2019
|
|
5 |
p. 330-331
|
artikel
|
| 118 |
Glycaemic index as part of the diabetes prevention strategy
|
Frost, Gary
|
|
|
|
5 |
p. 289-290
|
artikel
|
| 119 |
Going with your gut
|
Thorley, Jennifer
|
|
2015
|
|
5 |
p. 322-
1 p.
|
artikel
|
| 120 |
Growth hormone replacement therapy and fracture risk
|
Giustina, Andrea
|
|
2015
|
|
5 |
p. 307-308
2 p.
|
artikel
|
| 121 |
Growth monitoring as an early detection tool: a systematic review
|
Scherdel, Pauline
|
|
2016
|
|
5 |
p. 447-456
10 p.
|
artikel
|
| 122 |
Guidelines for management of diabetic ketoacidosis: time to revise?
|
Dhatariya, Ketan K
|
|
2017
|
|
5 |
p. 321-323
3 p.
|
artikel
|
| 123 |
Hacking diabetes: DIY artificial pancreas systems
|
Farrington, Conor
|
|
2017
|
|
5 |
p. 332-
1 p.
|
artikel
|
| 124 |
Health-care access of transgender people: a medical student approach
|
Pelzer, Benedikt W
|
|
2016
|
|
5 |
p. 388-389
2 p.
|
artikel
|
| 125 |
Health care and mental wellbeing in the transgender and gender-diverse Chinese population
|
Zhu, Xuequan
|
|
2019
|
|
5 |
p. 339-341
|
artikel
|
| 126 |
Healthy-food procurement: using the public plate to reduce food insecurity and diet-related diseases
|
Freudenberg, Nicholas
|
|
2016
|
|
5 |
p. 383-384
2 p.
|
artikel
|
| 127 |
How clinically relevant is statin-induced diabetes?
|
Gerstein, Hertzel C
|
|
|
|
5 |
p. 286-287
|
artikel
|
| 128 |
How should patients with adrenal incidentalomas be followed up?
|
Pivonello, Rosario
|
|
2014
|
|
5 |
p. 352-354
3 p.
|
artikel
|
| 129 |
How to create yourself
|
Cantor, Abi
|
|
2014
|
|
5 |
p. 368-
1 p.
|
artikel
|
| 130 |
25-hydroxyvitamin D concentrations during fetal life and bone health in children aged 6 years: a population-based prospective cohort study
|
Garcia, Audry H
|
|
2017
|
|
5 |
p. 367-376
10 p.
|
artikel
|
| 131 |
Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management
|
|
|
2019
|
|
5 |
p. 385-396
|
artikel
|
| 132 |
I'll have what they're having
|
Brownie, Sharon
|
|
2015
|
|
5 |
p. 392-
1 p.
|
artikel
|
| 133 |
Implantable insulin pumps: an effective option with restricted dissemination
|
Spaan, Nienke A
|
|
2014
|
|
5 |
p. 358-360
3 p.
|
artikel
|
| 134 |
Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
|
Stefan, Norbert
|
|
2014
|
|
5 |
p. 406-416
11 p.
|
artikel
|
| 135 |
Insulin access and affordability in the USA: anticipating the first interchangeable insulin product
|
Luo, Jing
|
|
|
|
5 |
p. 360-362
|
artikel
|
| 136 |
Insulin affordability
|
Hegele, Robert A
|
|
2017
|
|
5 |
p. 324-
1 p.
|
artikel
|
| 137 |
Insulin thermostability in a real-world setting
|
Pendsey, Sanket
|
|
|
|
5 |
p. 310-312
|
artikel
|
| 138 |
Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes
|
Standl, Eberhard
|
|
2017
|
|
5 |
p. 391-402
12 p.
|
artikel
|
| 139 |
João Raposo: moving beyond recommendations and guidelines
|
Burki, Talha
|
|
|
|
5 |
p. 313
|
artikel
|
| 140 |
Kidney failure: are we failing?
|
The Lancet Diabetes & Endocrinology,
|
|
2014
|
|
5 |
p. 349-
1 p.
|
artikel
|
| 141 |
Knowledge gaps and weight stigma shape attitudes toward obesity
|
O'Keeffe, Majella
|
|
|
|
5 |
p. 363-365
|
artikel
|
| 142 |
Leopard skin
|
Henneicke, Holger
|
|
|
|
5 |
p. 456
|
artikel
|
| 143 |
Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
|
van Dijk, Myrthe M
|
|
|
|
5 |
p. 322-329
|
artikel
|
| 144 |
Levothyroxine treatment in euthyroid women positive for thyroid peroxidase antibodies and recurrent pregnancy loss
|
Korevaar, Tim I M
|
|
|
|
5 |
p. 299-301
|
artikel
|
| 145 |
Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data
|
Sattar, Naveed
|
|
2016
|
|
5 |
p. 403-410
8 p.
|
artikel
|
| 146 |
Long COVID: the elephant in the room
|
The Lancet Diabetes & Endocrinology,
|
|
|
|
5 |
p. 297
|
artikel
|
| 147 |
Low-carbohydrate diets in type 2 diabetes
|
Tay, Jeannie
|
|
2019
|
|
5 |
p. 331-333
|
artikel
|
| 148 |
Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial
|
Cooper, Cyrus
|
|
2016
|
|
5 |
p. 393-402
10 p.
|
artikel
|
| 149 |
Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial
|
Ostadal, Petr
|
|
|
|
5 |
p. 330-340
|
artikel
|
| 150 |
Methodological considerations in D-health cancer mortality results
|
Egger, Sam
|
|
|
|
5 |
p. 307
|
artikel
|
| 151 |
Methodological considerations in D-health cancer mortality results – Authors' reply
|
Neale, Rachel E
|
|
|
|
5 |
p. 307-308
|
artikel
|
| 152 |
mHealth plus community health worker interventions: the future research agenda
|
Mishra, Shiva Raj
|
|
2016
|
|
5 |
p. 387-388
2 p.
|
artikel
|
| 153 |
mHealth plus community health worker interventions: the future research agenda – Author's reply
|
Rubinstein, Adolfo
|
|
2016
|
|
5 |
p. 388-
1 p.
|
artikel
|
| 154 |
New pharmacological strategies for protecting kidney function in type 2 diabetes
|
Muskiet, Marcel H A
|
|
2019
|
|
5 |
p. 397-412
|
artikel
|
| 155 |
NICE guidance on dapagliflozin for chronic heart failure with reduced ejection fraction
|
Adler, Amanda I
|
|
|
|
5 |
p. 261-263
|
artikel
|
| 156 |
Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes
|
Porrini, Esteban
|
|
2015
|
|
5 |
p. 382-391
10 p.
|
artikel
|
| 157 |
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
|
Ahlqvist, Emma
|
|
2018
|
|
5 |
p. 361-369
|
artikel
|
| 158 |
Obesity in children and adolescents: epidemiology, causes, assessment, and management
|
Jebeile, Hiba
|
|
|
|
5 |
p. 351-365
|
artikel
|
| 159 |
Obesity-related stigma—hiding in plain sight
|
The Lancet Diabetes & Endocrinology,
|
|
|
|
5 |
p. 349
|
artikel
|
| 160 |
On the occasion of International Women's Day
|
Anjana, R M
|
|
|
|
5 |
p. 312
|
artikel
|
| 161 |
Oral semaglutide in Japanese versus non-Japanese patients with type 2 diabetes
|
Scheen, André J
|
|
|
|
5 |
p. 350-352
|
artikel
|
| 162 |
PCSK9 inhibition in type 2 diabetes: so far so good, but not there yet
|
Santos, Raul D
|
|
2016
|
|
5 |
p. 377-379
3 p.
|
artikel
|
| 163 |
Peer guidance for young people with type 1 diabetes
|
Tucker, Miriam E
|
|
2018
|
|
5 |
p. 360
|
artikel
|
| 164 |
Pituitary acrogigantism and ectopic Cushing's syndrome
|
Boro, Hiya
|
|
|
|
5 |
p. 318
|
artikel
|
| 165 |
Pleiotropic effects of type 2 diabetes management strategies on renal risk factors
|
Muskiet, Marcel H A
|
|
2015
|
|
5 |
p. 367-381
15 p.
|
artikel
|
| 166 |
Post-exercise recovery for the endurance athlete with type 1 diabetes: a consensus statement
|
Scott, Sam N
|
|
|
|
5 |
p. 304-317
|
artikel
|
| 167 |
Precision nutrition for prevention and management of type 2 diabetes
|
Wang, Dong D
|
|
2018
|
|
5 |
p. 416-426
|
artikel
|
| 168 |
Prediction of cardiovascular disease worldwide
|
Moons, Karel G M
|
|
2015
|
|
5 |
p. 309-310
2 p.
|
artikel
|
| 169 |
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England
|
Khunti, Kamlesh
|
|
|
|
5 |
p. 293-303
|
artikel
|
| 170 |
Radically upgrading diabetes prevention in England
|
Maruthappu, Mahiben
|
|
2015
|
|
5 |
p. 312-313
2 p.
|
artikel
|
| 171 |
Rational combination therapy for type 2 diabetes
|
Del Prato, Stefano
|
|
2019
|
|
5 |
p. 328-329
|
artikel
|
| 172 |
Real-world insulin stability and global access
|
Weiss, Michael A
|
|
|
|
5 |
p. 307-309
|
artikel
|
| 173 |
Recent advances in the pharmacological management of hypercholesterolaemia
|
Ajufo, Ezim
|
|
2016
|
|
5 |
p. 436-446
11 p.
|
artikel
|
| 174 |
Renal trials in diabetes need a platform: time for a global approach?
|
de Zeeuw, Dick
|
|
2018
|
|
5 |
p. 356-358
|
artikel
|
| 175 |
Research capacity in Africa—will the sun rise again?
|
Davies, Justine
|
|
2016
|
|
5 |
p. 375-
1 p.
|
artikel
|
| 176 |
Research digest: the risks of type 2 diabetes at a young age
|
Sattar, Naveed
|
|
2017
|
|
5 |
p. 331-
1 p.
|
artikel
|
| 177 |
Research in brief
|
Kang, Seema
|
|
2015
|
|
5 |
p. 318-
1 p.
|
artikel
|
| 178 |
Research in brief
|
Kang, Seema
|
|
2018
|
|
5 |
p. 359
|
artikel
|
| 179 |
Research in brief
|
Kang, Seema
|
|
2016
|
|
5 |
p. 390-
1 p.
|
artikel
|
| 180 |
Research in brief
|
Kang, Seema
|
|
2014
|
|
5 |
p. 366-
1 p.
|
artikel
|
| 181 |
Research in brief
|
McIntosh, Kate V
|
|
2019
|
|
5 |
p. 342
|
artikel
|
| 182 |
Rethinking the label anti-obesity medication
|
Flint, Stuart W
|
|
|
|
5 |
p. 301-302
|
artikel
|
| 183 |
Retraction and republication—Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial
|
The Editors of The Lancet Diabetes & Endocrinology,
|
|
2019
|
|
5 |
p. 334
|
artikel
|
| 184 |
Reversible biological adaptations in obesity
|
Södersten, Per
|
|
2015
|
|
5 |
p. 314-
1 p.
|
artikel
|
| 185 |
Reversible biological adaptations in obesity – Authors' reply
|
Ochner, Christopher N
|
|
2015
|
|
5 |
p. 314-315
2 p.
|
artikel
|
| 186 |
Rising diabetes diagnosis in long COVID
|
Narayan, K M Venkat
|
|
|
|
5 |
p. 298-299
|
artikel
|
| 187 |
Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes
|
Ehrmann, Dominic
|
|
|
|
5 |
p. 436-446
|
artikel
|
| 188 |
Risks and burdens of incident diabetes in long COVID: a cohort study
|
Xie, Yan
|
|
|
|
5 |
p. 311-321
|
artikel
|
| 189 |
Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
|
Yabe, Daisuke
|
|
|
|
5 |
p. 392-406
|
artikel
|
| 190 |
Salt, hypertension, and proteinuria in diabetic nephropathy
|
Weir, Matthew R
|
|
2014
|
|
5 |
p. 351-352
2 p.
|
artikel
|
| 191 |
Semaglutide for obesity: four STEPs forward, but more to come
|
Ryan, Donna H
|
|
|
|
5 |
p. 252-254
|
artikel
|
| 192 |
Semaglutide, lipid-lowering drugs, and NAFLD
|
Katsiki, Niki
|
|
2017
|
|
5 |
p. 329-330
2 p.
|
artikel
|
| 193 |
Semaglutide, lipid-lowering drugs, and NAFLD – Author's reply
|
Sorli, Christopher
|
|
2017
|
|
5 |
p. 330-
1 p.
|
artikel
|
| 194 |
Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
|
Zinman, Bernard
|
|
2019
|
|
5 |
p. 356-367
|
artikel
|
| 195 |
SGLT2 inhibitors and GLP-1 receptor agonists: a sound combination
|
De Block, Christophe
|
|
2018
|
|
5 |
p. 349-352
|
artikel
|
| 196 |
SGLT2 inhibitors: providing cardiovascular protection in type 2 diabetes?
|
Wilding, John
|
|
2016
|
|
5 |
p. 379-381
3 p.
|
artikel
|
| 197 |
Skeletal protection in patients with primary hyperparathyroidism
|
Minisola, Salvatore
|
|
|
|
5 |
p. 352-353
|
artikel
|
| 198 |
Stigma: undermining public health
|
Mitchell, Fiona
|
|
|
|
5 |
p. 374
|
artikel
|
| 199 |
Subclinical Cushing's syndrome and cardiovascular disease
|
Anagnostis, Panagiotis
|
|
2014
|
|
5 |
p. 361-
1 p.
|
artikel
|
| 200 |
Sugar intake: lowering the bar
|
The Lancet Diabetes & Endocrinology,
|
|
2015
|
|
5 |
p. 305-
1 p.
|
artikel
|
| 201 |
Targeting non-alcoholic fatty liver disease through 11-βHSD1 inhibition
|
Ratziu, Vlad
|
|
2014
|
|
5 |
p. 354-356
3 p.
|
artikel
|
| 202 |
Targeting PCSK9 inhibitors to those who will benefit most
|
Turner, Traci A
|
|
|
|
5 |
p. 301-303
|
artikel
|
| 203 |
The effect of monthly vitamin D supplementation on fractures: a tertiary outcome from the population-based, double-blind, randomised, placebo-controlled D-Health trial
|
Waterhouse, Mary
|
|
|
|
5 |
p. 324-332
|
artikel
|
| 204 |
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes
|
Grant, William B
|
|
2014
|
|
5 |
p. 364-
1 p.
|
artikel
|
| 205 |
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes
|
Bischoff-Ferrari, Heike A
|
|
2014
|
|
5 |
p. 363-364
2 p.
|
artikel
|
| 206 |
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes
|
Anagnostis, Panagiotis
|
|
2014
|
|
5 |
p. 362-363
2 p.
|
artikel
|
| 207 |
The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes – Authors' reply
|
Bolland, Mark J
|
|
2014
|
|
5 |
p. 364-365
2 p.
|
artikel
|
| 208 |
The Human Insulin Thermal Solution project—a private sector initiative to address the thermostability of insulin
|
Rasmussen, Mats
|
|
|
|
5 |
p. 292-294
|
artikel
|
| 209 |
The importance of language in engagement between health-care professionals and people living with obesity: a joint consensus statement
|
Albury, Charlotte
|
|
|
|
5 |
p. 447-455
|
artikel
|
| 210 |
The ISPAD Clinical Practice Consensus Guidelines 2022: how far we have come and the distance still to go
|
Bruggeman, Brittany S
|
|
|
|
5 |
p. 304-307
|
artikel
|
| 211 |
The many faces of diabetes: addressing heterogeneity of a complex disease
|
Sladek, Rob
|
|
2018
|
|
5 |
p. 348-349
|
artikel
|
| 212 |
The NHS long-term plan: a comparison of the narrative used for cancer and obesity
|
Flint, Stuart W
|
|
|
|
5 |
p. 355-357
|
artikel
|
| 213 |
The relevance of T3 in the management of hypothyroidism
|
Salvatore, Domenico
|
|
|
|
5 |
p. 366-372
|
artikel
|
| 214 |
The things that make us human
|
Stirrups, Robert
|
|
2019
|
|
5 |
p. 343
|
artikel
|
| 215 |
Thinking broader in diabetes care
|
The Lancet Diabetes & Endocrinology,
|
|
|
|
5 |
p. 299
|
artikel
|
| 216 |
Towards a trial-based definition of vitamin D deficiency
|
Reid, Ian R
|
|
2016
|
|
5 |
p. 376-377
2 p.
|
artikel
|
| 217 |
Type 1 diabetes: heterogeneity in heritability
|
Leslie, Richard David
|
|
|
|
5 |
p. 287-289
|
artikel
|
| 218 |
Type 1 diabetes in Finland: past, present, and future
|
Knip, Mikael
|
|
|
|
5 |
p. 259-260
|
artikel
|
| 219 |
Type 1 diabetes—origins and epidemiology
|
Howard, Sarah G
|
|
|
|
5 |
p. 367-368
|
artikel
|
| 220 |
Type 1 diabetes—origins and epidemiology
|
Virtanen, Suvi M
|
|
|
|
5 |
p. 368-369
|
artikel
|
| 221 |
Type 1 diabetes—origins and epidemiology – Authors' reply
|
Norris, Jill M
|
|
|
|
5 |
p. 369-370
|
artikel
|
| 222 |
Type 2 diabetes: treating not managing
|
Morris, Elizabeth
|
|
2019
|
|
5 |
p. 326-327
|
artikel
|
| 223 |
Urbanisation, inequality, and non-communicable disease risk
|
The Lancet Diabetes & Endocrinology,
|
|
2017
|
|
5 |
p. 313-
1 p.
|
artikel
|
| 224 |
Vitamin D and fractures
|
Reid, Ian R
|
|
|
|
5 |
p. 301-302
|
artikel
|
| 225 |
Vitamin D, obesity, and risk of diabetes
|
Boucher, Barbara
|
|
2014
|
|
5 |
p. 361-362
2 p.
|
artikel
|
| 226 |
Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials
|
Jolliffe, David A
|
|
|
|
5 |
p. 276-292
|
artikel
|
| 227 |
Vitamin D supplements and future fracture risk among Mongolian schoolchildren
|
Ma, Ning
|
|
|
|
5 |
p. 300
|
artikel
|
| 228 |
Vitamin D supplements and future fracture risk among Mongolian schoolchildren – Author's reply
|
Martineau, Adrian R
|
|
|
|
5 |
p. 300-301
|
artikel
|
| 229 |
Vitamin D to prevent acute respiratory infections
|
Lips, Paul
|
|
|
|
5 |
p. 249-251
|
artikel
|
| 230 |
Vitamin D: 100 years of discoveries, yet controversy continues
|
Gallagher, J Christopher
|
|
|
|
5 |
p. 362-374
|
artikel
|
Tijdschrift beschrijving